Lumexa Imaging Holdings Inc

Lumexa Imaging Holdings Inc(LMRI)股票分析

$10.780

0.000 (0.00%)收盤時

Loading chart…
最高
11.000
開盤
10.810
成交量加權均價
10.80
成交量
318.53K
市值
—
最低
10.610
成交金額
3.44M
企業價值/稅息折舊攤銷前利潤(TTM)
20.75

Lumexa Imaging Holdings, Inc. is a national provider of diagnostic imaging services. The Company offers a range of advanced imaging services (MRI, CT and PET scans) and routine diagnostic and screening imaging services (X-ray, ultrasound and mammography). The Company’s segments include Outpatient Imaging Centers (Outpatient) and Professional Services (Professional). The Outpatient segment consists of imaging centers that are owned or operated by it (either wholly owned or via unconsolidated affiliate), where it performs the imaging scan and provides the radiologist’s interpretation service. The Professional segment consists of professional interpretation services, where the imaging scan itself is performed at the hospital or point of care and not by it or its unconsolidated affiliates. The Company and its affiliates operate outpatient imaging center footprint in the United States, spanning 184 centers across 13 states and includes eight joint venture partnerships with health systems.

AI 分析 of Lumexa Imaging Holdings Inc (LMRI)

買進

Lumexa Imaging Holdings, Inc. is a good buy right now due to its recent positive earnings surprise of 233.33% and a current price of $10.78, which is significantly below analyst price targets of $18 from both Truist and KeyBanc. The company has shown a recovery in net income with a positive net income of $2.74 million in Q2 2026, indicating a turnaround in profitability. However, the main risk is its high debt to equity ratio of 144.68%, which could impact financial stability if not managed carefully.

估值指標

Lumexa Imaging Holdings Inc(LMRI)目前預期本益比為 0.00,5 年平均預期本益比為 0.00。

預期本益比

嚴重低估
5 年均值 P/E
0.00
目前P/E
0.00
高估
0.00
低估
0.00

預期 EV/EBITDA

合理
5 年均值 EV/EBITDA
35.60
目前EV/EBITDA
20.75
高估
60.04
低估
11.17

預期股價營收比

合理
5 年均值 P/S
0.90
目前P/S
0.92
高估
1.20
低估
0.60

持有 LMRI 的大戶

S

Seven Grand Managers LLC

+ 持有LMRI

-1.91%

3個月報酬率

事件時間軸

2026-08-12 (ET)

17:00:00

Lumexa Imaging Reports Q2 Revenue of $264.16M

17:00:00

Company Adjusts FY26 Revenue Outlook to $1.05B-$1.1B

2026-06-02 (ET)

07:30:00

Lumexa Imaging Forms Strategic Joint Venture with Hospital for Special Surgery

2026-04-20 (ET)

07:10:00

Lumexa Imaging Appoints Kyle Lynch as Chief Growth Officer

2026-03-26 (ET)

09:40:00

Lumexa Imaging Holdings Inc Trading Halted Due to Volatility

資訊

LMRI 常見問題 —— 由 Alphio AI 解答

Lumexa Imaging Holdings, Inc. is a national provider of diagnostic imaging services. The Company offers a range of advanced imaging services (MRI, CT and PET scans) and routine diagnostic and screening imaging services (X-ray, ultrasound and mammography). The Company’s segments include Outpatient Imaging Centers (Outpatient) and Professional Services (Professional). The Outpatient segment consists of imaging centers that are owned or operated by it (either wholly owned or via unconsolidated affiliate), where it performs the imaging scan and provides the radiologist’s interpretation service. The Professional segment consists of professional interpretation services, where the imaging scan itself is performed at the hospital or point of care and not by it or its unconsolidated affiliates. The Company and its affiliates operate outpatient imaging center footprint in the United States, spanning 184 centers across 13 states and includes eight joint venture partnerships with health systems. It operates in the Healthcare sector.

Lumexa Imaging Holdings, Inc. is a good buy right now due to its recent positive earnings surprise of 233.33% and a current price of $10.78, which is significantly below analyst price targets of $18 from both Truist and KeyBanc. The company has shown a recovery in net income with a positive net income of $2.74 million in Q2 2026, indicating a turnaround in profitability. However, the main risk is its high debt to equity ratio of 144.68%, which could impact financial stability if not managed carefully.

暫無貼文

註冊或登入後參與討論

本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。

開始交易